Journal of Cardiovascular Development and Disease,
Год журнала:
2023,
Номер
10(6), С. 244 - 244
Опубликована: Май 31, 2023
Surgical
mortality
risk
scores,
even
if
not
properly
designed
and
rarely
tested
in
the
transcatheter
aortic
valve
implantation
(TAVI)
setting,
still
guide
heart
team
managing
significant
stenosis.After
splitting
1763
consecutive
patients
retrospectively
based
on
their
thresholds,
composite
endpoint
early
safety
(ES)
was
adjudicated
according
to
Valve
Academic
Research
Consortium
(VARC)-2
-3
consensus
documents.ES
incidence
higher
VARC-2
rather
than
VARC-3
defined.
Despite
only
showing
ES
had
significantly
lower
absolute
values
of
all
three
main
these
last
failed
foresee
both
intermediate-risk
patients.
The
receiver
operating
characteristic
analysis
also
showed
a
correlation,
but
with
poor
diagnostic
accuracy,
among
scores
ES;
moreover,
absence
low-osmolar
contrast
media
administration
were
identified
as
independent
predictors
1-year
ES,
respectively.
Finally,
single
complication
included
definition
could
affect
mortality.Currently,
most
used
do
have
adequate
accuracy
predicting
after
TAVI.
VARC-2,
instead
VARC-3,
is
an
predictor
mortality.
Kardiologia Polska,
Год журнала:
2023,
Номер
81(4), С. 330 - 337
Опубликована: Апрель 28, 2023
Transcatheter
aortic
valve
replacement
(TAVI)
has
evolved
into
the
gold
standard
management
option
for
high-risk
patients
with
severe
stenosis.
Despite
identifying
procedural,
electrocardiographic,
and
clinical
predictors
of
important
post-procedural
conduction
disturbances
(left
bundle
branch
block
high-degree
atrioventricular
block)
despite
continuous
technological
refinement
transcatheter
valves,
rate
disturbance
remains
high
challenging
to
manage.
New
strategies
are
required
reduce
overall
permanent
pacemaker
implantations.
In
this
article,
we
will
review
incidence,
predictive
factors,
implications
after
TAVI.
Journal of Cardiovascular Development and Disease,
Год журнала:
2023,
Номер
10(6), С. 244 - 244
Опубликована: Май 31, 2023
Surgical
mortality
risk
scores,
even
if
not
properly
designed
and
rarely
tested
in
the
transcatheter
aortic
valve
implantation
(TAVI)
setting,
still
guide
heart
team
managing
significant
stenosis.After
splitting
1763
consecutive
patients
retrospectively
based
on
their
thresholds,
composite
endpoint
early
safety
(ES)
was
adjudicated
according
to
Valve
Academic
Research
Consortium
(VARC)-2
-3
consensus
documents.ES
incidence
higher
VARC-2
rather
than
VARC-3
defined.
Despite
only
showing
ES
had
significantly
lower
absolute
values
of
all
three
main
these
last
failed
foresee
both
intermediate-risk
patients.
The
receiver
operating
characteristic
analysis
also
showed
a
correlation,
but
with
poor
diagnostic
accuracy,
among
scores
ES;
moreover,
absence
low-osmolar
contrast
media
administration
were
identified
as
independent
predictors
1-year
ES,
respectively.
Finally,
single
complication
included
definition
could
affect
mortality.Currently,
most
used
do
have
adequate
accuracy
predicting
after
TAVI.
VARC-2,
instead
VARC-3,
is
an
predictor
mortality.
